tiprankstipranks
Trending News
More News >
ImmunoPrecise Antibodies (IPA)
NASDAQ:IPA
Advertisement

ImmunoPrecise Antibodies (IPA) Revenue

Compare
355 Followers

ImmunoPrecise Antibodies Revenue

ImmunoPrecise Antibodies had a revenue of 6.15M in the quarter ending Sep 30, 2025, with 0.42%. This bring the company's revenue in the last twelve months to 24.00M, Increased -0.29%. In the fiscal year ending Dec 31, 2025, ImmunoPrecise Antibodies had annual revenue of 24.52M with <0.01% growth.
Revenue (ttm)
24.00M
Revenue Growth
-3.20%
P/S Ratio
3.80
Revenue/Employee
$340,556
Employees
72
Market Cap
$93.23M

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2025
24.52M2.00K<+0.01%
Dec 31, 2024
24.52M3.85M+18.65%
Dec 31, 2023
20.66M1.30M+6.72%
Dec 31, 2022
19.36M1.45M+8.11%
Dec 31, 2021
17.91M3.85M+27.41%
Dec 31, 2020
14.06M3.13M+28.67%
Dec 31, 2019
10.93M5.48M+100.80%
Dec 31, 2018
5.44M2.81M+106.85%
Dec 31, 2017
2.63M734.40K+38.73%
Dec 31, 2016
1.90M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis